Avadel Pharmaceuticals (NASDAQ:AVDL) Coverage Initiated at Deutsche Bank Aktiengesellschaft
Analysts at Deutsche Bank Aktiengesellschaft assumed coverage on shares of Avadel Pharmaceuticals (NASDAQ:AVDL – Get Free Report) in a research report issued on Tuesday, Marketbeat.com reports. The firm set a “buy” rating and a $12.00 price target on the stock. Deutsche Bank Aktiengesellschaft’s price target points to a potential upside of 34.68% from the company’s […]
Analysts at Deutsche Bank Aktiengesellschaft assumed coverage on shares of Avadel Pharmaceuticals (NASDAQ:AVDL – Get Free Report) in a research report issued on Tuesday, Marketbeat.com reports. The firm set a “buy” rating and a $12.00 price target on the stock. Deutsche Bank Aktiengesellschaft’s price target points to a potential upside of 34.68% from the company’s […]
